For sales

📢Highlights from the Week of October 6 to October 13, 2025   in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of October 6 to October 13, 2025 ( FDA, Approval ) SQ Innovation gains FDA approval for Lasix® ONYU to treat edema in heart failure ( FDA, Approval ) Celltrion’s EYDENZELT (aflibercept‑boav) gets FDA approval to treat wet AMD, DME, diabetic retinopathy and RVO‑related macular edema ( FDA, Approval ) Regeneron’s LIBTAYO (cemiplimab‑rwlc) is approved in the US as the first immunotherapy for adjuvant treatment of high‑risk CSCC after surgery and radiation ( EMA ) EMA accepts marketing application for AVT23, Alvotech’s biosimilar to XOLAIR (omalizumab) Pg 1/2 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.